XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Compensation (Tables)
 6 Months Ended
Jul. 29, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
The following table provides share-based compensation expense and the related income tax impacts for the thirteen and twenty-six weeks ended July 29, 2023 and July 30, 2022:
Thirteen Weeks EndedTwenty-Six Weeks Ended
(in thousands)July 29, 2023July 30, 2022July 29, 2023July 30, 2022
Share-based compensation expense$11,559 $7,760 $19,647 $16,116 
Income tax benefit associated with share-based compensation expense recognized1,079 1,015 2,083 1,980 
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]
The following table provides discrete income tax benefits and charges related to share-based compensation awards during the thirteen and twenty-six weeks ended July 29, 2023 and July 30, 2022:
Thirteen Weeks EndedTwenty-Six Weeks Ended
(in thousands)July 29, 2023July 30, 2022July 29, 2023July 30, 2022
Income tax discrete benefits (charges) realized for tax deductions related to the issuance of shares$325 $(113)$1,442 $1,998 
Income tax discrete charges realized upon cancellation of stock appreciation rights— (8)(101)(203)
Total income tax discrete benefits (charges) related to share-based compensation awards$325 $(121)$1,341 $1,795 
Employee tax withheld by company for share-based compensation
The following table provides the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and twenty-six weeks ended July 29, 2023 and July 30, 2022:
Thirteen Weeks EndedTwenty-Six Weeks Ended
(in thousands)July 29, 2023July 30, 2022July 29, 2023July 30, 2022
Employee tax withheld upon issuance of shares (1)
$410 $312 $18,769 $14,006 
(1)    Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows.
Schedule of Restricted Stock Unit Activity
The following table provides the summarized activity for restricted stock units for the twenty-six weeks ended July 29, 2023:
Service-based Restricted
Stock Units		Performance-based Restricted
Stock Units		Market-based Restricted
Stock Units
Number of 
Underlying
Shares		Weighted-
Average Grant
Date Fair Value		Number of 
Underlying
Shares		Weighted-
Average Grant
Date Fair Value		Number of 
Underlying
Shares		Weighted-
Average Grant
Date Fair Value
Unvested at January 28, 20232,461,395 $21.30 336,549 $31.08 662,137 $23.68 
Granted883,296 28.66 222,144 28.36 111,077 41.20 
Adjustments for performance achievement
— — — — 493,854 16.24 
Vested(906,730)19.48 — — (987,708)16.24 
Forfeited(74,456)25.02 (7,123)— (3,562)43.46 
Unvested at July 29, 2023 (1)
2,363,505 $24.65 551,570 $30.00 275,798 $43.81 
(1)    Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved at up to 200% of their target vesting amount.
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The following table provides the unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of July 29, 2023:
Service-based Restricted
Stock Units		Performance-based Restricted
Stock Units		Market-based Restricted
Stock Units
Unrecognized compensation cost (in thousands)
$46,071 $14,810 $6,969 
Remaining weighted-average period cost is expected to be recognized (years)1.31.71.7
Schedule of Stock Appreciation Rights Activity
The following table provides the summarized stock appreciation rights activity for the twenty-six weeks ended July 29, 2023:
Number of
Underlying
Shares		Weighted-Average
Exercise Price
Aggregate
Intrinsic Value
 (in thousands)
Weighted-Average
Remaining
Contractual Life (years)
Outstanding at January 28, 2023190,589 $29.43 
Exercised(13,788)23.19 
Forfeited or expired(23,700)45.69 
Outstanding at July 29, 2023
153,101 $27.47 $1,914 1.3
Stock appreciation rights exercisable at July 29, 2023153,101 $27.47 $1,914 1.3


The following table provides additional information pertaining to stock appreciation rights exercised during the twenty-six weeks ended July 29, 2023:
(in thousands)July 29, 2023
Total grant date fair value of awards exercised$115 
No stock appreciation rights were exercised during the twenty-six weeks ended July 30, 2022.
Market-based restricted stock units [Member]  
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions additional information pertaining to restricted stock units for the twenty-six weeks ended July 29, 2023 and July 30, 2022:
Twenty-Six Weeks Ended
(in thousands)July 29, 2023July 30, 2022
Service-based restricted stock units:
Total grant date fair value of awards granted$25,315 $27,173 
Total grant date fair value of awards vested17,663 15,393 
Performance-based restricted stock units:
Total grant date fair value of awards granted6,300 5,300 
Total grant date fair value of awards vested— 4,482 
Market-based restricted stock units:
Total grant date fair value of awards granted4,576 3,731 
Total grant date fair value of awards vested16,040 4,105 
The following table provides the weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the twenty-six weeks ended July 29, 2023 and July 30, 2022:
Twenty-Six Weeks Ended
July 29, 2023July 30, 2022
Grant date market price$28.36 $32.07 
Fair value41.20 45.15 
Price volatility63 %66 %
Expected term (years)2.92.9
Risk-free interest rate4.6 %2.3 %
Dividend yield— — 
Average volatility of peer companies66.0 72.9 
Average correlation coefficient of peer companies0.52950.5146